Yew Bio Pharm Income Statement - Quarterly (OTCMKTS:YEWB)

Add to My Stocks
$0.2 $0 (0%) YEWB stock closing price Jul 19, 2017 (Closing)

Looking at financial statements, along with the Yew Bio Pharm stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. The income statement is a summary of the revenue, expenses and profitability (shown as Net Income) or lack of it. The income statement for YEWB which implies a QoQ revenue decline of $4.12M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The operating expenses (also check: Yew Bio Pharm assets and Yew Bio Pharm free cash flow) as shown in the Yew Bio Pharm profit and loss statement 2017-Q1 total to $7.64M. This line item has decreased from $13.41M compared with last quarter. View details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4
Yew Bio Pharm Net Sales or Revenues
7.88M12M14.67M16.06M8.62M17.27M5M4.67M2.64M1.9M
Cost Of Goods Sold (COGS)7.35M13.24M13.24M14.41M7.22M15.52M3.57M2.28M1.17M0.9M
Yew Bio Pharm Gross Profit
0.51M-1.21M1.41M1.64M1.39M1.78M1.41M2.37M1.47M1.01M
Research & Development Expense----------
Selling General & Admin Expense0.29M0.17M0.29M0.34M0.31M0.46M0.48M0.48M0.47M0.41M
Income Before Depreciation Depletion Amortization0.22M-1.36M1.11M1.3M1.07M1.32M0.93M1.89M0.99M0.61M
Depreciation Depletion Amortization----------
Non Operating Income-0.05M-0.04M-0.03M--0.02M0.05M-0.11M--
Interest Expense----------
Yew Bio Pharm Pretax Income
0.16M-1.41M1.08M1.3M1.05M1.38M0.93M2M0.99M0.61M
Provision for Income Taxes-0.01M----0.04M--0.04M-
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations0.17M-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Net Income (Profit/Loss)
0.17M-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M0.61M
Average Shares used to compute Diluted EPS56.67M51.88M51.89M51.88M51.88M51.88M52.19M57.62M58.23M-
Average Shares used to compute Basic EPS51.88M51.88M51.88M51.88M51.88M51.88M52.16M52.13M52.13M-
Income Before Nonrecurring Items0.17M-1.43M1.08M1.31M1.05M1.39M0.93M2.01M0.96M-
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
--0.030.020.030.020.030.020.040.02-
Yew Bio Pharm Earnings Per Share Diluted Net
--0.030.020.030.020.030.020.030.02-
EPS Diluted Before Nonrecurring Items--0.030.020.030.020.030.020.030.02-
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

The key things to look for in an income statement while doing Yew Bio Pharm stock analysis are:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: Yew Bio Pharm revenue chart) implies that the company is growing, which has not been the case with Yew Bio Pharm. One must stay away from stocks whose revenues are declining.
  • Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $7.88M - other expenses = $0.17M for YEWB stock. An improving bottomline implies that the company is growing profits.
The income statement is also called statement of revenue and expense. The financials along with Yew Bio Pharm historical stock prices provides a lot of details about the firm. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
8.6960
PS ratio (
price sales ratio
)
0.2050
Operating margin
2.8
Net profit margin
2.2
Dividend yield
0%